Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Pernille B Jørgensen, Denmark
  • Astrid Helene Livbjerg
  • ,
  • Hans J Hansen, Denmark
  • Thor Petersen, Denmark
  • Per Höllsberg
Multiple sclerosis (MS) is associated with Epstein-Barr virus (EBV) infection, but impaired immune suppression may be part of the disease pathogenesis. CD8(+) T cells that are restricted by HLA-E exert an important immunoregulatory mechanism. To explore how EBV might interfere with immune regulation, we examined the expression of HLA-E and the frequency of CD8(+) cells recognizing HLA-E, presenting either an EBV peptide from the BZLF1 protein or a signal sequence peptide from HLA-A2, in relapsing remitting (MS-RR), primary progressive (MS-PP) MS patients, and healthy controls (HC). Treatment with IFN-α or EBV increased HLA-E expression on CD4(+) cells. However, only MS-PP had increased expression of HLA-E on resting CD4(+) cells when compared with HC (p
Original languageEnglish
JournalP L o S One
Volume7
Issue9
Pages (from-to)e46120
Number of pages9
ISSN1932-6203
DOIs
Publication statusPublished - 2012

See relations at Aarhus University Citationformats

ID: 52800386